PeptideStack
5.2kquestions
20kanswers
220users

Why did my HbA1c move after twelve weeks on orforglipron?

Asked 2 Apr 2025Modified 12 months agoViewed 17k times
18

Concretely: HbA1c · twelve weeks · orforglipron.

I have two candidate explanations and no way to distinguish them.

The same procedure has worked without incident several times previously, which argues against technique.

Should I be treating this as a failure or as noise?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
shareeditfollowflag
NA
askednoor_alhassan11k272 Apr 2025
5Is there a repeat draw, or is this a single value? One value is a point, not a trend. – rhian_prydderch 10 months ago
4Which equation produced the eGFR? They disagree by enough to matter at the margins. – hana_petrikova 8 months ago
add a comment

4 Answers

Accepted answer first, then by votes
67

Accepted answer

12 weeks is 84 days, and the first question about any marker is whether 84 days is long enough for it to have finished moving. HbA1c is a weighted average of the preceding ninety days or so, with the most recent thirty contributing about half of it. Against that, day 84 is about 7 per cent pre-treatment blood, so the change in front of you is a fraction of the change already in train. The second question is the denominator. Weight loss moves plasma volume, muscle mass and intake at once, and several of the markers on a routine panel are ratios with one of those three underneath them. Repeat before interpreting. A single value 84 days in, with no baseline drawn under the same conditions, is a number rather than a change — and nothing here is medical advice.

Start with a baseline. A result taken before anything started converts most later ambiguity into a simple comparison, and it cannot be obtained retrospectively.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Headline results, principal programmes

TrialAgentnDurationPrimary result
STEP 1Semaglutide 2.4 mg1,96168 wk−14.9 % vs −2.4 % weight
STEP 2Semaglutide 2.4 mg, T2DM1,21068 wk−9.6 % vs −3.4 % weight
SURMOUNT-1Tirzepatide 5/10/15 mg2,53972 wk−15 / −19 / −21 % weight
SURMOUNT-4Tirzepatide, withdrawal67088 wkContinued loss vs substantial regain
SELECTSemaglutide 2.4 mg17,604~40 moMACE HR 0.80 (0.72–0.90)
FLOWSemaglutide 1.0 mg, CKD3,533~3.4 yrRenal composite reduced; stopped early
SURMOUNT-OSATirzepatide, OSA46952 wkAHI reduced with and without PAP

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Decide the action for each result before you order the test.

shareimprove this answerflag
DF
answered · acceptedDr_Nadia_Farsi104k24719 Jun 2025
7Thank you — separating "out of range" from "abnormal" is the distinction I needed. – h_pergande 2 months ago
6Same laboratory every time is advice I ignored for a year, and the series was useless because of it. – lipid_panel_q 1 days ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
25

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

edited 18 Jul 2025 by pierce_count — added the placebo-arm figures

shareimprove this answerflag
PC
answeredpierce_count24k3830 Jun 2025
5I would add a sentence about baseline: without one, the second panel is a snapshot rather than a trend. – Dr_Ilse_Vandenberg 2 months ago
add a comment
18

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Put another way, a twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
AM
answeredaine_mulcahy28k2728 May 2025
14

The short version: a small, well-chosen panel with a baseline beats a large one without.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Research-use compounds are not approved for human use, and no panel makes that safer.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
SB
answereds_bhattacharya31k388 Jun 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.